Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives
نویسندگان
چکیده
منابع مشابه
Beta-blockers in Cardiovascular Disease: Do not throw out the baby with the bathwater.
1 Three decades ago, prior to the use of anti-platelets and reperfusion therapy for patients with myocardial infarction (MI), intravenous beta-blocker was shown to produce a small although clinically significant benefit in reducing the combined end-point of death, cardiac arrest or reinfarction . Subsequently, a review of 29,260 patients in 51 short term trials showed that early beta-blocker us...
متن کاملCardiovascular Protection Using Beta-Blockers
For more than 3 decades, beta-blockers have been widely used in the treatment of hypertension and are still recommended as first-line agents by national and international guidelines. Recent meta-analyses indicate that, in patients with uncomplicated hypertension, compared with other antihypertensive agents, first-line therapy with beta-blockers was associated with an increased risk of stroke, e...
متن کاملAutophagy mediates the metabolic benefits of endurance training.
In a recent issue of Nature, He et al demonstrate that autophagy is required for optimal physical endurance as well as for the beneficial effects of exercise on glucose and lipid metabolism. These data not only shed new insights into the mechanisms whereby exercise is healthy, but also indirectly strengthen the notion that autophagy exerts lifespan-extending effects. Macroautophagy (hereafter r...
متن کاملBenefits of Spinning Training and Green Tea on Risk Factors of Cardiovascular in Overweight Women
Background and Aim: Sedentary life style increases risk of cardiovascular diseases (CVDs). Physical activity and green tea supplementation can reduce cardiovascular risk factors by improving inflammation and body composition. The aim of study was to determine benefits of 8 weeks of spinning training and green tea supplementation on risk factors cardiovascular and body composition in overweight ...
متن کاملReview: cardioselective beta-blockers do not produce adverse respiratory effects in COPD.
M e t h o d s Data sources: Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE/ Excerpta Medica, CINAHL, respiratory journals, meeting abstracts, and relevant references (up to May 2005). Study selection and assessment: Randomized, blinded, controlled trials (RCTs) in any language that evaluated cardioselective β-blockers as a single dose or for an extended period in patients with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Human Hypertension
سال: 2007
ISSN: 0950-9240,1476-5527
DOI: 10.1038/sj.jhh.1002173